Use of dronedarone to prepare medicament to prevent mortality and/or cardiovascular hospitalizations in patients having e.g. history of atrial fibrillation/atrial flutter, cerebrovascular accident and non-rheumatic valvular heart disease

摘要

Use of dronedarone or its salt for the preparation of a medicament for the prevention of mortality and/or cardiovascular hospitalizations in patients having a history of atrial fibrillation or atrial flutter, is claimed. ACTIVITY : Cardiovascular-Gen; Metabolic. MECHANISM OF ACTION : Potassium channel modulator.